FDA Approves Clinical Trial of Drug to Treat Eye Cancer
WVU Cancer Institute
Mark McLaughlin, PhD—a researcher with the WVU Cancer Institute and Modulation Therapeutics Inc.—and his colleagues are developing a cancer treatment that zeroes in on the…